...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: USA ZHCLF investors

"True, but given that I sold all my RVX shares and put a sizeable portion of the proceeds into ZHCLF shares, I'm unable to fully appreciate this flip-side problem."

haha...got a chuckle out of that one. 

Good discussion!

 

Koo

Share
New Message
Please login to post a reply